Scott Husson, distinguished professor in Chemical and Biomolecular Engineering, received a grant from the National Institute of General Medical Sciences, entitled: “Fast-Track: Improving therapeutic protein purification with new, high-productivity multimodal membranes”.
In this Fast-Track SBIR project, Dr. Husson will work with Purilogics, LLC to develop a new class of membrane chromatography columns that can rapidly and selectively purify therapeutic proteins produced by cell culture technologies. Therapeutic proteins are among the most effective treatments for severe and chronic conditions such as cancers and autoimmune disorders.
There is tremendous demand for new therapeutic molecules and personalized medicines. Biomanufacturers are moving towards multidrug facilities to meet this demand, and many are moving to small batch production runs to increase manufacturing flexibility and counteract market risks. The proposed research is expected to have a significant impact on the industry and contribute to improving human health by designing membrane products that support faster changeovers in these multidrug facilities.